3DMed

COVID-19 integrated detection solution supplier


Founded in 2010, 3DMed is a precision medicine leader in China dedicated to making early and personalized diagnosis accessible to every patient. They are setting the standard for innovation in automated molecular diagnostics and artificial intelligence (AI) to help doctors use genetic information to tailor treatment to individual patients.

3DMed clinical laboratory is accredited by College of American Pathologists (CAP) and certified by Clinical Laboratory Improvement Amendments (CLIA) to provide clinical testing in various disease areas.

In 2018, 3DMed introduced an AI-based cancer genome data interpretation system, the ANDiS Genome Insight. The following year, 3DMed launched an industry-leading, fully closed, automated NGS library preparation system, the ANDiS 400.

3DMed aims to be a game changer by offering a diverse pipeline of automated molecular diagnostics.

Shortly after the 2019 coronavirus outbreak (COVID-2019), 3DMed responded quickly by developing a series of RT-qPCR-based tests for qualitative detection of SARS-CoV-2 RNA in upper and lower respiratory specimens collected from individuals meeting the CDC criteria for SARS-CoV-2 testing.

Main product lines

  • Sampling
  • Sample preparation
  • Nucleic acid extraction
  • qPCR set up
  • qPCR detection

Main products

  • ANDiS SARS-CoV-2 RT-qPCR Detection Kit
  • ANDiS SARS-CoV-2 & Influenza A/B RT-qPCR Detection Kit

Please contact our sales team if you require specific products or prices.